NCT03405363View on ClinicalTrials.gov

Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists

CompletedOBSERVATIONAL
Enrollment

65,406

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

February 3, 2020

Study Completion Date

February 3, 2020

Conditions
Pulmonary Disease, Chronic Obstructive
Trial Locations (1)

Unknown

Aarhus Universitets hospital Skejby, Aarhus

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03405363 - Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists | Biotech Hunter | Biotech Hunter